Sign in
CompletedPhase 4

N-acetylcysteine for the treatment of cannabis dependence: working mechanisms

Key facts

Who runs it
UZ Brussel
Where
Belgium1 site in 1 countryChoose a country to see its sites
Status
Completed
Phase
Phase 4
People taking part
50 people enrolled
Started
15 Jan 2025
Ended
17 Feb 2026
Type of study
Interventional
Record updated
15 January 2025

Who can take part

Age
18 years to 64 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • Males, aged 18-45 years
  • Current DSM-IV diagnosis of cannabis dependence
  • >1 week detoxified and abstinent
  • Able to provide written informed consent and to comply with study procedures
  • Dutch speaking (Dutch as primary language)

Who cannot take part

  • Known hypersensitivity or allergy to n-acetylcysteine, or receiving chronic therapy with medication that could interact adversely with n-acetylcysteine within 30 days prior to randomization (i.e., nitroglycerin, ACE inhibitors or antihypertensive drugs, anti-coagulants)
  • History of any major internal disease (including diabetes, cardiovascular disease, lung disease, liver or kidney disease)
  • An active or any history of neurological disorder, including but not limited to seizure disorder, epilepsy, stroke, neurological disease, cognitive impairment, head trauma with prolonged loss of consciousness (>10 minutes), or migraine headaches
  • An active or a history of a psychiatric disorder including, but not limited to, depression, schizophrenia, bipolar disorder, anxiety, or other psychiatric disorders
  • Currently dependent on any substance other than cannabis, alcohol or nicotine
  • Asthma

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

To evaluate the working mechanisms of N-acetylcysteine for the treatment of cannabis dependence

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).
Record updated
15 January 2025